Aktuelle Publikationen zu TKTL1
- TKTL1 als gültiger Marker für Staging, Rezidivbildung und Überlebensrate
Transketolase-Like 1 Expression Is Modulated during Colorectal Cancer Progression and Metastasis Formation
Diaz-Moralli, S et al, PLoS ONE (2011) Volume 6 | Issue 9 | e25323
[Studie]
- TKTL1-Expression lässt Therapieresistenzen schon vor Therapiebeginn erkennen
Schwaab et al: Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. BMC Cancer 2011, 11:363 [Studie] [Zusammenfassung in deutsch]
- Die Bedeutung von TKTL1 auch bei Lungenkrebs
Kayser G et al: Poor outcome in primary non-small cell lung cancers is predicted by transketolase TKTL1 expression
December 2011 - Volume 43 - Issue 7 - p 719-724 doi: 10.1097/PAT.0b013e32834c352b Anatomical Pathology [Abstract] [Zusammenfassung in deutsch]
- Die Bedeutung von TKTL1 auch bei Lungenkrebs
Aktuelle Publikationen zur EDIM-Technologie
- Nachweis von TKTL1 und Apo10 mit EDIM
O. Feyen et al, Cell Symposia 2012:
EDIM blood test: a non-invasive method to detect patients with malignancies
- Abstract Reference NO: 0115 [Abstract]A. Rotmann et al, FIGO 2012:
Apo10 - a new biomarker for early detection of disorders of cell proliferation and solid tumours. Submission Number/Control ID: 1358244. [Abstract]O. Feyen et al, Anticancer Research ISSN 0250-7005:
EDIM-TKTL1 blood test for reliable pre-selection of cancer patients eligible for FDG-PET/CT imaging. [Publikation]J. Arnhold, Anticancer Research ISSN 0250-7005:
Therapy monitoring and early detection of metastasis using tumor protein detection in macrophages. [Publikation]A. Rotmann et al., Poster FIGO 2009:
TKTL1 - a new biomarker and its relevance in the daily gynaecological practice. [Poster]V. Prasad et al., Poster SNM 2010:
Transketolase-like 1 (TKTL1), a new intracellular marker for staging of non-small cell lung cancer (NSCLC): Correlation with metabolic tumor size on F-18 FDG PET/CT. [Poster]
- Nachweis von PSA mit EDIM
Leers MPG et al, AJCP 2008 129 649-656:
Circulating PSA-Containing Macrophages as a Possible Target for the Detection of Prostate Cancer. [Publikation]
- Nachweis von CEA mit EDIM
Japink D et al, Anticancer Research 2009 29 3245-3252:
CEA in Activated Macrophages. New Diagnostic Possibilities for Tumor Markers in Early Colorectal Cancer. [Publikation]
